Drug intelligence / Profile preview

Elemene

Development stage
Phase 4
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous, Oral
01

Overview

Elemene refers to a group of natural sesquiterpene compounds extracted primarily from the rhizome of Curcuma wenyujin and Curcuma zedoaria. The main active component is β-elemene (beta-elemene), which exhibits broad-spectrum antitumor activity and is used clinically in China as an injectable or oral emulsion for cancer therapy. Elemene acts through multiple mechanisms including cell cycle arrest via modulation of cyclin-dependent kinases, induction of apoptosis by affecting proteins such as survivin, caspase family members, and Bcl-2 family proteins, inhibition of tumor angiogenesis and metastasis through regulation of VEGF and matrix metalloproteinases, reversal of multidrug resistance in cancer cells, modulation of key signaling pathways such as Wnt/β-catenin, Notch, PI3K/Akt/mTOR, MAPK/ERK pathways, STAT3 transcription factor regulation. It has also been shown to enhance immune function and improve the efficacy while reducing side effects when combined with chemotherapy regimens. Approved by the Chinese regulatory authority for use in gliomas and brain metastases as well as adjuvant treatment for esophageal and gastric cancers.

Brand names
Elemene Injection
Other names
β-elemenebeta-elemeneγ-elemenedelta-elemenegamma-elemeneδ-elemene
02

Targets

ABCB1 (P-glycoprotein)CASP6 (Caspase-6)MMP2 (Matrix metalloproteinase-2)MicrotubuleSTAT3 (Signal Transducer and Activator of Transcription 3)BCL-2 (BCL-2 family)CASP (Caspase family)CDK (CDK family)MMP12 (Macrophage Metalloelastase)NOTCH (Neurogenic locus notch homolog protein 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Elemene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elemene.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call